Investing Profile

Dan Becker

InvestorVC
Managing Director at Access Biotechnology
accessbio-tech.comNew York, New York
Photo of Dan Becker, Managing Director at Access Biotechnology

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Access Biotechnology Managing Director
$100K - $5.0M
$1.5M
15
CompanyStageDateRound SizeTotal Raised
Hemab
Series COct 2025$160M
Series BFeb 2023$140M
$290M
Co-investors: Uya Chuluunbaatar (Amzak Health Investors), Christine Borowski (Access Biotechnology)
Day One Biopharmaceuticals
Post Ipo EquityJul 2024$180M
Series BFeb 2021$130M
Series AMay 2020$60M
$370M
GRO Biosciences
Series BJul 2024$60M
$60M
Mariana Oncology
Series BSep 2023$180M
Series ADec 2021$75M
$250M
Zurp
Pre SeedJan 2023$5M
$5M
Co-investors: Niklas Jansen
Matchpoint Therapeutics
Series AOct 2022$70M
$70M
ACELYRIN
Series CSep 2022$300M
$300M
Curie Therapeutics
Series ADec 2021$75M
$75M